Skip to content
PoliticalRepoPoliticalRepo

United Kingdom · Motion · Early Day Motion

EDM 253

ADVICE OF NICE

openUnited Kingdom· UK Parliament· EN

Introduced

12 January 2000

Last action

12 January 2000 · Early Day Motion

Status

0

Sponsors

Paul Flynn

Subjects

Discovery layer

Source updated

12 January 2000

Summary

That this House welcomes the guidance of NICE that zanamivir (Relenza) should not be prescribed because it has little effect on flu symptons; deplores the crude opportunism of Glaxo Wellcome in exploiting the present flu season by attempting to pressurise the Government to reject the advice of NICE; and urges the Government to resist the covetous propaganda of the pharmaceutical lobby and to continue to make their decisions on the basis of impartial scientific evidence in the best interest of patients.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 12 January 2000

    Early Day Motion

    That this House welcomes the guidance of NICE that zanamivir (Relenza) should not be prescribed because it has little effect on flu symptons; deplores the crude opportunism of Glaxo Wellcome in exploiting the present flu season by attempting to pressurise the Government to reject the advice of NICE; and urges the Government to resist the covetous propaganda of the pharmaceutical lobby and to continue to make their decisions on the basis of impartial scientific evidence in the best interest of patients.

    Source: Early Day Motion

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.